Young girls with malignant ovarian germ cell tumors can undergo normal menarche and menstruation after fertility-preserving surgery and adjuvant chemotherapy

Acta Obstetricia et Gynecologica Scandinavica

Volumn 89, Issue 1, 2010, Pages 126-130

  Yoo, Seung Chul ^a   Kim, Woo Young ^a   Yoon, Jong Hyuck ^a   Chang, Suk Joon ^a   Chang, Ki Hong ^a   Ryu, Hee Sug ^a  

^a Ajou University School of Medicine   (South Korea)

Author keywords

Fertility preserving surgery; Malignant ovarian germ cell tumor; Premenarche

Indexed keywords

ANTINEOPLASTIC AGENT; TUMOR MARKER;

ADJUVANT CHEMOTHERAPY; ADOLESCENT; ARTICLE; BLOOD; CHILD; FEMALE; HUMAN; LYMPHADENECTOMY; MENARCHE; MENSTRUATION; NEOPLASM; OVARY TUMOR; PATHOPHYSIOLOGY; PRESCHOOL CHILD; RETROSPECTIVE STUDY; TERATOMA;

ADOLESCENT; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CHEMOTHERAPY, ADJUVANT; CHILD; CHILD, PRESCHOOL; FEMALE; HUMANS; LYMPH NODE EXCISION; MENARCHE; MENSTRUATION; NEOPLASMS, GERM CELL AND EMBRYONAL; OVARIAN NEOPLASMS; RETROSPECTIVE STUDIES; TERATOMA; TUMOR MARKERS, BIOLOGICAL;

EID: 74049130185     PISSN: 00016349     EISSN: 16000412     Source Type: Journal    
DOI: 10.3109/00016340903348383     Document Type: Article

References (30)

1. Mitchell PL, Al-Nasiri N, A'Hern R, Fisher C, Horwich A., Pinkerton CR, et al Treatment of nondysgerminomatous ovarian germ cell tumors: an analysis of 69 cases. Cancer. 1999; 85:2232-44.
2. Gershenson DM. Management of ovarian germ cell tumors. J Clin Oncol. 2007; 25:2938-43.
3. Abu-Rustum N.R., Aghajanian C. Management of malignant germ cell tumors of the ovary. Semin Oncol. 1998; 25:235-42.
4. Peccatori F, Bonazzi C, Chiari S., Landoni F, Colombo N, Mangioni C. Surgical management of malignant ovarian germ-cell tumors: 10 years' experience of 129 patients. Obstet Gynecol. 1995; 86:367-72.
5. Tewari K, Cappuccini F, Disaia P.J., Berman ML, Manetta A, Kohler MF Malignant germ cell tumors of the ovary. Obstet Gynecol. 2000; 95:128-33.
6. Ayhan A, Celik H, Taskiran C., Bozdag G, Aksu T. Oncologic and reproductive outcome after fertility-saving surgery in ovarian cancer. Eur J Gynaecol Oncol. 2003; 24:223-32.
7. Lu KH, Gershenson DM Update on the management of ovarian germ cell tumors. J Reprod Med. 2005; 50:417-25.
8. Terenziani M, Massimino M, Casanova M., Cefalo G, Ferrari A, Luksch R., et al Childhood malignant ovarian germ cell tumors: A monoinstitutional experience. Gynecol Oncol. 2001; 81:436-40.
9. Brewer M, Gershenson DM, Herzog C.E., Mitchell MF, Silva EG, Wharton JT Outcome and reproductive function after chemotherapy for ovarian dysgerminoma. J Clin Oncol. 1999; 17:2670-75.
10. Zanetta G, Bonazzi C, Cantu M., Binidagger S, Locatelli A, Bratina G., et al Survival and reproductive function after treatment of malignant germ cell ovarian tumors. J Clin Oncol. 2001; 19:1015-20.
11. Sagae S, Sasaki H, Nishioka Y., Terasawa K, Kudo R. Reproductive function after treatment of malignant germ cell ovarian tumors. Mol Cell Endocrinol. 2003; 202:117-21.
12. Billmire D, Vinocur C, Rescorla F., Cushing B, London W, Schlatter M., et al Outcome and staging evaluation in malignant germ cell tumors of the ovary in children and adolescents: An intergroup study. J Pediatr Surg. 2004; 39:424-9.
13. Beiner ME, Gotlieb WH, Korach Y, Shrim A., Stockheim D, Segal Y, et al Cystectomy for immature teratoma of the ovary. Gynecol Oncol. 2004; 93:381-4.
14. Low JJ, Perrin LC, Crandon A.J., Hacker NF Conservative surgery to preserve ovarian function in patients with malignant ovarian germ cell tumors. A review of 74 cases. Cancer. 2000; 89:391-8.
15. Tangir J, Zelterman D, Ma W., Schwartz PE Reproductive function after conservative surgery and chemotherapy for malignant germ cell tumors of the ovary. Obstet Gynecol. 2003; 101:251-7.
16. Nishio S, Ushijima K, Fukui A., Fujiyoshi N, Kawano K, Komai K., et al Fertility-preserving treatment for patients with malignant germ cell tumors of the ovary. J Obstet Gynaecol Res. 2006; 32:416-21.
17. Gershenson DM, Miller AM, Champion V.L., Monahan PO, Zhao Q, Cella D, et al Reproductive and sexual function after platinum-based chemotherapy in long-term ovarian germ cell tumor survivors: a gynecologic oncology group study. J Clin Oncol. 2007; 25:2792-7.
18. FIGO cancer committee. Staging announcement. Gynecol Oncol. 1986; 25:383-5.
19. Serov SF, Scully RE, Sobin L.H., World Health Organization. Histological typing of ovarian tumours. Geneva, World Health Organization, 1973.
20. de La Motte Rouge T, Pautier P, Duvillard P, Rey A, Morice P, Haie-Meder C, et al. Survival and reproductive function of 52 women treated with surgery and bleomycin, etoposide, cisplatin (BEP) chemotherapy for ovarian yolk sac tumor. Ann Oncol. 2008; 19:1435-41.
21. Chan JK, Tewari KS, Waller S, Cheung M.K., Shin JY, Osann K, et al The influence of conservative surgical practices for malignant ovarian germ cell tumors. J Surg Oncol. 2008; 98:111-6.
22. De Backer A., Madern GC, Oosterhuis J.W., Hakvoort-Cammel FG, Hazebroek FW Ovarian germ cell tumors in children: a clinical study of 66 patients. Pediatr Blood Cancer. 2006; 46:459-64.
23. Sklar CA, Mertens AC, Mitby P, Whitton J., Stovall M, Kasper C, et al Premature menopause in survivors of childhood cancer: A report from the childhood cancer survivor study. J Natl Cancer Inst. 2006; 98:890-6.
24. Meirow D, Nugent D. The effects of radiotherapy and chemotherapy on female reproduction. Hum Reprod Update. 2001; 7:535-43.
25. Chemaitilly W, Mertens AC, Mitby P, Whitton J., Stovall M, Yasui Y, et al Acute ovarian failure in the childhood cancer survivor study. J Clin Endocrinol Metab. 2006; 91:1723-8.
26. Blumenfeld Z, Eckman A. Preservation of fertility and ovarian function and minimization of chemotherapy-induced gona-dotoxicity in young women by gnrh-a. J Natl Cancer Inst Monogr. 2005; 40-3.
27. Blumenfeld Z. How to preserve fertility in young women exposed to chemotherapy? The role of gnrh agonist cotreat-ment in addition to cryopreservation of embrya, oocytes, or ovaries. Oncologist. 2007; 12:1044-54.
28. Williams SD, Birch R, Einhorn L.H., Irwin L., Greco FA, Loehrer PJ Treatment of disseminated germ-cell tumors with cisplatin, bleomycin, and either vinblastine or etoposide. N Engl J Med. 1987; 316:1435-40.
29. Gershenson DM, Morris M, Cangir A., Kavanagh JJ, Stringer CA, Edwards CL, et al Treatment of malignant germ cell tumors of the ovary with bleomycin, etoposide, and cisplatin. J Clin Oncol. 1990; 8:715-20.
30. Williams S, Blessing JA, Liao S.Y., Ball H., Hanjani P. Adjuvant therapy of ovarian germ cell tumors with cisplatin, etoposide, and bleomycin: A trial of the gynecologic oncology group. J Clin Oncol. 1994; 12:701-6.